{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:10:20Z","timestamp":1789265420649,"version":"build-2803163510"},"reference-count":78,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG\/2021\/005069"],"award-info":[{"award-number":["CRG\/2021\/005069"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,9,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Antibiotic resistance in\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      causes major concern worldwide. In\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      , efflux pumps are mostly responsible for the development of multidrug resistance. Active removal of antibiotics from cells by\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      efflux pumps, including NorA, NorB, AbcA, and MepA, helps to lower their intracellular concentration and effectiveness. The present study examined two FDA-approved antifungal medications, oxiconazole and sertaconazole, as possible efflux pump inhibitors (EPIs) against multidrug-resistant\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      . Our results showed that both drugs reduced the efflux pump activity of drug-susceptible (ATCC25923) and multidrug-resistant (Mu50)\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      strains. While sertaconazole inhibited the efflux pumps without changing the efflux rate, oxiconazole lowered both efflux pump activity and efflux rate. Neither of these drugs impacted bacterial membrane integrity nor bacterial growth. Both drugs enhanced the efficacy of norfloxacin, cefotaxime, and moxifloxacin by lowering the MIC values and showed minimal cytotoxicity toward mammalian cells. In combination with the antibiotics, both sertaconazole and oxiconazole significantly lowered the bacterial load in a murine skin infection model. Our results suggested that the drugs altered the proton motive force (PMF), which resulted in diminished membrane potential (\u0394\n                      <jats:italic toggle=\"yes\">\u03a8<\/jats:italic>\n                      ) and an increased electrochemical gradient (\u0394pH), thereby inhibiting ATP production and efflux pump activity. The safety profile and potential to enhance antibiotic efficacy suggest that sertaconazole and oxiconazole may be used as EPIs for combating multidrug-resistant\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      infections. Further studies are required to assess their pharmacokinetics, toxicity, and activity against a wide range of\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      isolates.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.00320-25","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T13:00:27Z","timestamp":1754312427000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["Inhibition of efflux pumps by FDA-approved drugs oxiconazole and sertaconazole restores antibiotic susceptibility in multidrug-resistant\n                    <i>S. aureus<\/i>"],"prefix":"10.1128","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0439-5065","authenticated-orcid":true,"given":"Suvendu","family":"Ojha","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00x1rrc95","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious Disease Biology, Institute of Life Sciences","place":["Bhubaneswar, India"]},{"id":[{"id":"https:\/\/ror.org\/00nc5f834","id-type":"ROR","asserted-by":"publisher"}],"name":"Regional Centre for Biotechnology","place":["Faridabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Chatterjee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00x1rrc95","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious Disease Biology, Institute of Life Sciences","place":["Bhubaneswar, India"]},{"id":[{"id":"https:\/\/ror.org\/00nc5f834","id-type":"ROR","asserted-by":"publisher"}],"name":"Regional Centre for Biotechnology","place":["Faridabad, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3352-4508","authenticated-orcid":true,"given":"Tushar Kant","family":"Beuria","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00x1rrc95","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Infectious Disease Biology, Institute of Life Sciences","place":["Bhubaneswar, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3010"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00134-14"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00007709"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy270"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00826-09"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11070951"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.5772\/67338"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10050593"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.4178\/epih\/e2015020"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874285801307010059"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.4103\/joacp.JOACP_349_15"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.09.028"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.3934\/medsci.2022018"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.21946"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2019.12.008"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl5849"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-021-02612-1"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1104\/pp.86.1.1"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-596935-2.50004-9"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1005485107"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.15698\/mic2024.11.839"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.7.2.223"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.3934\/microbiol.2018.1.1"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16020170"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/157489106777452692"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_2079_17"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13030197"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-020-00160-9"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174151"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10121502"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02762"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.00951-21"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272417"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00840-16"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1754-1611-3-18"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2019.06.002"},{"key":"e_1_3_5_38_2","unstructured":"CLSI EUCAST. 2025. M100 performance standards for antimicrobial susceptibility testing a CLSI supplement for global application"},{"key":"e_1_3_5_39_2","unstructured":"CLSI EUCAST. 2024. Eucast: AST of bacteria. Available from: https:\/\/www.eucast.org\/ast_of_bacteria"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.suppl_1.5"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00497-10"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2021.101543"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12860-020-00316-8"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02863-22"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3469525"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.3758\/bf03193146"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-127-32768"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700810"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59012-4"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/ani13010143"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2014.04.007"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02766-2"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-006-0679-8"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.102"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S71623"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.05031-22"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.70679"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-009-0680-1"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106098"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2005.07.007"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.1.85"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03191381"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/6.suppl_A.55"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.1997.tb00466.x"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874285801307010072"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0074-7696(04)42005-1"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0320(19990101)35:1<55::aid-cyto8>3.0.co;2-2"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.15406\/jbmoa.2018.06.00167"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0048-6"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1039\/C4MD00196F"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.30954\/2277-940X.04.2023.2"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12071168"},{"key":"e_1_3_5_73_2","unstructured":"Inxight Drugs. 1988 Oxiconazole. Available from: https:\/\/drugs.ncats.io\/drug\/C668Q9I33J"},{"key":"e_1_3_5_74_2","unstructured":"Oxiconazole nitrate | C18H14Cl4N4O4 | CID 9556529 - PubChem. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/9556529"},{"key":"e_1_3_5_75_2","unstructured":"Oxistat. Prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2004\/19828slr009 20209slr005_oxistat_lbl.pdf"},{"key":"e_1_3_5_76_2","unstructured":"Drug approval package: Ertaczo (Sertaconazole nitrate) NDA #021385. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-385_Ertaczo.cfm"},{"key":"e_1_3_5_77_2","unstructured":"Drug approval package. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-385_Ertaczo.cfm"},{"key":"e_1_3_5_78_2","unstructured":"Sertaconazole nitrate. Available from: https:\/\/drugs.ncats.io\/drug\/1DV05410M5. Retrieved 07 Feb 2025."},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-024-06440-z"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00320-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00320-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T13:01:40Z","timestamp":1756904500000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00320-25"}},"subtitle":[],"editor":[{"given":"Benjamin P.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":78,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,3]]}},"alternative-id":["10.1128\/aac.00320-25"],"URL":"https:\/\/doi.org\/10.1128\/aac.00320-25","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"2025-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00320-25"}}